Global Information Inc. is pleased to announce a new Conference, "Third Annual Biomarker Assay Development" by Cambridge Healthtech Institute. This 3-day event will help attendees adopt the right technologies to create useful and reliable biomarker assays.
Day one features and topics:
- Challenges in Pre-Clinical to Clinical Translation
- Pre-Clinical Hepatotoxicity Biomarker Discovery
- Safety Biomarkers in Action: Pre-Clinical to Clinical Translation
Day two features and topics:
- Proteomic and Biochemical Assays
- Biomarkers in the Development of BTK and HDAC Inhibitors
- A Central Role for Flow Cytometry in the Fit-for-Purpose Validation of Phosphorprotein Biomarker Assays
- Development of Drug-Inducced Vascular Injury (DIVI) Biomarkers
- Using Mass Spectrometry and Immunoassays to Discover and Validate Serum Protein Biomarkers for Islet Autoimmunity and Type 1 Diabetes
- Genomic and Metabolomic Tools
- Exploiting an Unexpected Value of PCR Technology to Predict Efficiency of Anti-Cancer Drugs
- Analyzing miR-122 as a Biomarker for Heptotoxicity
- Metabolomic Screening for Pregnancy Complications
Day three features and topics:
- Imaging tools for cell and tissue markers
- Image-Based Method for Measuring a Tissue Biomarker in Archived Clinical Samples
- Multi-Modality Nanoprobes for Molecular Imaging
- Seeing Renal Stress and Injury in Real-Time: The Ngal Reporter Mouse Detects the Response of Distal Tubular Segments in vivo
- What Do Your Biomarkers Do? Insights from Multiphoton Imaging
Featured Presentations:
- Establishing the Context for Introducing New Safety Biomarkers into Clinical Trials
- Development of Biomarker Panels: Opportunities and Challenges
- Applications of MRI and PET Approaches for Assessing Cell Function
